These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1153 related articles for article (PubMed ID: 6227420)

  • 1. Therapeutic evaluation of five nitrosoureas in a human melanoma xenograft system.
    Osieka R; Glatte P; Pannenbäcker R; Schmidt CG
    Cancer Chemother Pharmacol; 1983; 11(3):147-52. PubMed ID: 6227420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of four newly synthesized 2-chloroethylnitrosoureas in comparison with BCNU, CCNU, MeCCNU, chlorozotocin and hydroxyethyl-CNU in preterminal rat leukemia L 5222.
    Zeller WJ; Eisenbrand G; Fiebig HH
    J Cancer Res Clin Oncol; 1979 Sep; 95(1):43-9. PubMed ID: 159309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
    Weiss RB; Issell BF
    Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
    [No Abstract]   [Full Text] [Related]  

  • 4. Nitrosoureas in the management of disseminated malignant melanoma.
    Ahmann DL
    Cancer Treat Rep; 1976 Jun; 60(6):747-51. PubMed ID: 782696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cancer chemotherapy with special reference to pharmacokinetics of nitrosoureas].
    Wakui A
    Gan To Kagaku Ryoho; 1982 Aug; 9(8):1327-38. PubMed ID: 6223595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitrosoureas: a review of experimental antitumor activity.
    Schabel FM
    Cancer Treat Rep; 1976 Jun; 60(6):665-98. PubMed ID: 782694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Fluosol-DA/O2 on tumor-cell and bone-marrow cytotoxicity of nitrosoureas in mice bearing FSA-II fibrosarcoma.
    Teicher BA; Holden SA; Rose CM
    Int J Cancer; 1986 Aug; 38(2):285-8. PubMed ID: 3089945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical comparison of the nitrosoureas.
    Wasserman TH; Slavik M; Carter SK
    Cancer; 1975 Oct; 36(4):1258-68. PubMed ID: 1100221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical and clinical studies on chlorozotocin, a new nitrosourea with decreased bone marrow toxicity.
    Macdonald JS; Hoth D; Schein PS
    Recent Results Cancer Res; 1980; 70():83-9. PubMed ID: 6444466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of semustine-induced cytotoxicity by chlorpromazine and caffeine in a human melanoma xenograft.
    Osieka R; Glatte P; Pannenbäcker R; Schmidt CG
    Cancer Treat Rep; 1986 Oct; 70(10):1167-71. PubMed ID: 3756939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized trial of chlorozotocin, neocarzinostatin, or methyl-CCNU in patients with malignant melanoma.
    Von Hoff DD; Amato DA; Kaufman JH; Falkson G; Cunningham TJ
    Am J Clin Oncol; 1984 Apr; 7(2):135-9. PubMed ID: 6230929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of nitrosourea resistant sublines of Lewis lung tumour following MeCCNU treatment in vivo.
    Stephens TC; Adams K; Peacock JH
    Br J Cancer; 1986 Feb; 53(2):237-45. PubMed ID: 3954945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticancer activity of new nitrosoureas against Walder carcinosarcoma 256 and DMBA-induced mammary cancer of the rat.
    Fiebig HH; Eisenbrand G; Zeller WJ; Zentgraf R
    Oncology; 1980; 37(3):177-83. PubMed ID: 6444708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cure rates and tumor resistance in cured mice after nitrosourea treatment of EMT6 ascites tumors.
    Feola JM; Maruyama Y
    Oncology; 1986; 43(6):372-7. PubMed ID: 2949185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrosourea combinations in lung cancer.
    Livingston RB
    Cancer Treat Rep; 1976 Jun; 60(6):757-760. PubMed ID: 182365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of new nitrosoureas on Yoshida sarcoma ascites cells implanted into the colon wall of rats.
    Habs M; Reinbold H; Eisenbrand G; Bhide S; Goga-Ionescu S; Schmähl D
    J Cancer Res Clin Oncol; 1981; 101(3):285-302. PubMed ID: 7309781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitization by chlorpromazine (CPZ) and caffeine (C) in human melanoma xenografts sensitive or resistant to methyl-CCNU (semustine).
    Osieka R; Glatte P; Schmidt CG
    Strahlenther Onkol; 1989 Jul; 165(7):526-8. PubMed ID: 2749491
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant nitrosourea therapy for glioblastoma.
    Brisman R; Housepian EM; Chang C; Duffy P; Balis E
    Arch Neurol; 1976 Nov; 33(11):745-50. PubMed ID: 985152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The level of DNA interstrand crosslinking in bone marrow parallels the extent of myelosuppression in mice treated with four chloroethylnitrosoureas.
    Bedford P; Berger MR; Eisenbrand G; Schmähl D
    J Cancer Res Clin Oncol; 1984; 108(1):141-7. PubMed ID: 6235230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitrosoureas as single agents in the treatment of pulmonary cancer.
    Wolf J
    Cancer Treat Rep; 1976 Jun; 60(6):753-6. PubMed ID: 782697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 58.